Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.5B | 14.5B | 15.0B | 16.4B |
Cost of revenue | 10.0B | 8.0B | 8.2B | 9.5B |
Gross profit | 7.6B | 6.5B | 6.8B | 6.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.9B | 2.7B | 2.5B | 2.4B |
Operating income | 2.9B | 2.1B | 2.6B | 2.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.3B | 1.3B | 1.2B | 1.0B |
Other income expense | — | — | — | — |
Pretax income | 1.8B | 946.3M | 1.7B | 2.1B |
Tax provision | 527.4M | 267.4M | 414.2M | 549.6M |
Net income | 1.3B | 678.9M | 1.2B | 1.6B |
Basic EPS | — | 4.9 | 8.8 | 11.0 |
Diluted EPS | — | 4.9 | 8.7 | 10.9 |
Basic average shares | — | 145.2M | 145.1M | 144.9M |
Diluted average shares | — | 145.8M | 145.9M | 145.6M |
EBITDA | 3.3B | 2.7B | 3.1B | 3.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | 44.8M | 34.1M | 25.9M | 28.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |